AmoyDx Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Public

  • Employees
  • 1,101

Employees

  • Stock Symbol
  • 300685

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $2.84
  • (As of Friday Closing)

AmoyDx General Information

Description

Amoy Diagnostics Co Ltd is the pharmaceutical company based in China. The company primarily focuses on molecular diagnostics for oncology precision medicine. It provides diagnostic products and services for medicine development and clinical oncology practice. The company's products include gene mutation, nucleic acid extraction, and molecular diagnostic kits comprising EGFR, RAS, ALK, BRAF, PIK3CA, and ROS1 testing kits.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
SHE
Corporate Office
  • 39 Dingshan Road
  • Haicang District
  • Xiamen, Fujian 361027
  • China
+86 0592 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AmoyDx Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.84 $2.82 $2.05 - $4.42 $1.13B 399M 4.15M $0.08

AmoyDx Financials Summary

In Thousands,
USD
TTM 30-Sep-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 1,249,471 1,417,182 2,525,611 2,565,261
Revenue 134,756 125,054 142,020 105,432
EBITDA 32,420 49,482 44,622 32,148
Net Income 30,242 39,163 37,102 26,102
Total Assets 242,305 239,289 238,446 198,529
Total Debt 7,253 7,775 951 636
Public Fundamental Data provided by Morningstar, Inc. disclaimer

AmoyDx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AmoyDx‘s full profile, request access.

Request a free trial

AmoyDx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Amoy Diagnostics Co Ltd is the pharmaceutical company based in China. The company primarily focuses on molecular diagnos
Biotechnology
Xiamen, China
1,101 As of 2022
000.00
00000000000 000.00

000000

aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi
0000000000000
Junction City, KS
00 As of 0000
0000000000

000000

em ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor inci
0000000000000
Louisville, CO
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AmoyDx Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InVitria Corporation Junction City, KS 00 0000000000
Biodesix Formerly VC-backed Louisville, CO 000 00000 000000000 00000
Teknova Formerly VC-backed Hollister, CA 000 000.00 00000000 000.00
Lonza Group Corporation Basel, Switzerland 00000 00000 000000000000 00000
Cytiva Corporate Backed or Acquired Marlborough, MA 00000 0000000000
You’re viewing 5 of 5 competitors. Get the full list »

AmoyDx Patents

AmoyDx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4328920-A1 Microsatellite instability detection method based on second-generation sequencing Pending 20-Apr-2021 000000000
US-20230146580-A1 Constructing method of genomic scar model Pending 07-Sep-2020 000000000
EP-4213152-A1 Method for establishing genomic scar model Pending 07-Sep-2020 000000000
EP-4089184-A1 Disposable reagent kit for detecting multiple genetic mutations of lung cancer Pending 10-Jan-2020 0000000000
EP-3674413-A1 Probe and method for high-throughput sequencing targeted capture target region used for detecting gene mutations as well as known and unknown gene fusion types Pending 26-Jan-2018 C12Q1/6855
To view AmoyDx’s complete patent history, request access »

AmoyDx Executive Team (6)

Name Title Board Seat Contact Info
Frank Zheng Deputy General Manager & Director of the Executive Board
Luo Fei Deputy General Manager & Director of the Executive Board
Zheng Huibin Deputy General Manager & Director of the Executive Board
Luo Jiemin General Manager & Director of the Executive Board
Mike Zhu Executive Vice President
You’re viewing 5 of 6 executive team members. Get the full list »

AmoyDx Board Members (2)

Name Representing Role Since
Li-Mou Zheng Ph.D AmoyDx Founder & Chairman 000 0000
You’re viewing 1 of 2 board members. Get the full list »

AmoyDx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AmoyDx Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Universal Sequencing Technology 24-May-2018 00000 0000 000 Biotechnology 00-000 00
To view AmoyDx’s complete investments history, request access »

AmoyDx ESG

Risk Overview

Risk Rating

Updated September, 27, 2023

31.83 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 16,173

Rank

00.00

Percentile

Healthcare

Industry

00 of 631

Rank

00.00

Percentile

Medical Devices

Subindustry

00 of 221

Rank

00.00

Percentile

To view AmoyDx’s complete esg history, request access »

AmoyDx FAQs

  • When was AmoyDx founded?

    AmoyDx was founded in 2008.

  • Where is AmoyDx headquartered?

    AmoyDx is headquartered in Xiamen, China.

  • What is the size of AmoyDx?

    AmoyDx has 1,101 total employees.

  • What industry is AmoyDx in?

    AmoyDx’s primary industry is Biotechnology.

  • Is AmoyDx a private or public company?

    AmoyDx is a Public company.

  • What is AmoyDx’s stock symbol?

    The ticker symbol for AmoyDx is 300685.

  • What is the current stock price of AmoyDx?

    As of 12-Apr-2024 the stock price of AmoyDx is $2.84.

  • What is the current market cap of AmoyDx?

    The current market capitalization of AmoyDx is $1.13B.

  • What is AmoyDx’s current revenue?

    The trailing twelve month revenue for AmoyDx is $135M.

  • Who are AmoyDx’s competitors?

    InVitria, Biodesix, Teknova, Lonza Group, and Cytiva are competitors of AmoyDx.

  • What is AmoyDx’s annual earnings per share (EPS)?

    AmoyDx’s EPS for 12 months was $0.08.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »